Chronic inflammation and DNA damage can then result in cancer formation
Allurion to increase focus on low-dose GLP-1 combination therapy and muscle mass maintenance owenhaskins Aug 6, 2025 3 min read Allurion Technologies has revealed a strategic direction with an increasing focus on low-dose GLP-1 combination therapy, muscle mass maintenance and US market entry
Ameliorating inflammation in an in vitro model by screening the anti-inflammatory and immunomodulatory roles of putative probiotics in inflammatory bowel disease
For maximum glow & brightening With the Booster Pro, you can enhance the brightening effect and achieve extremely healthy and glowing skin
Earl Stewart Jr., an internal medicine physician and medical director of health equity with Wellstar Health System, has seen many times how climate and extreme weather can impact health
A study on the clinico-epidemiological profile of vitiligo patients and its association with endocrine, audiological and ocular abnormalities